Taipei Veterans General Hospital, Taiwan: Carcinoma, Hepatocellular trials

The registry lists 11 Carcinoma, Hepatocellular studies with Taipei Veterans General Hospital, Taiwan as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 1Phase 4 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCCRecruitingNCT06594744Phase 4
• Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular CarcinomaRecruitingNCT06384950Not applicable
• Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal VaricesRecruitingNCT01970748Phase 4
• Prevention of Hand-foot Skin ReactionCompletedNCT04568330Not applicable
• REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN)Status unknownNCT03292991
• Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC PatientsStatus unknownNCT03273608
• DAA in the Risk of Recurrence After Curative Treatment of HCCWithdrawnNCT02959359Phase 4
• Prophylactic Antibiotics Before RFA for HCCStatus unknownNCT02534961Phase 4
• A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)Status unknownNCT01451658Phase 4
• Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation TherapyStatus unknownNCT01270178
• Study in Asia of the Combination of TACE With Sorafenib in HCC PatientsStatus unknownNCT00990860Phase 2